NASDAQ:AMEDAmedisys Stock Price, Forecast & News

Amedisys' stock was trading at $170.47 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, AMED shares have increased by 19.8% and is now trading at $204.14. View which stocks have been most impacted by Coronavirus.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amedisys in the last year. There are currently 4 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Amedisys.

Amedisys is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Amedisys.

Amedisys Inc (NASDAQ:AMED) released its quarterly earnings results on Wednesday, May, 6th. The health services provider reported $1.05 earnings per share for the quarter, topping analysts' consensus estimates of $0.97 by $0.08. The health services provider had revenue of $491.70 million for the quarter, compared to the consensus estimate of $507.45 million. Amedisys had a return on equity of 23.09% and a net margin of 6.43%. Amedisys's revenue was up 5.3% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.11 earnings per share. View Amedisys' earnings history.

14 brokerages have issued 1-year price objectives for Amedisys' shares. Their forecasts range from $125.00 to $240.00. On average, they expect Amedisys' share price to reach $191.43 in the next year. This suggests that the stock has a possible downside of 6.2%. View analysts' price targets for Amedisys.

News stories about AMED stock have trended negative this week, InfoTrie reports. The research group identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Amedisys earned a news sentiment score of -2.8 on InfoTrie's scale. They also assigned headlines about the health services provider a news buzz of 7.0 out of 10, indicating that recent press coverage is likely to have an impact on the stock's share price in the near future. View the latest news about Amedisys.

Amedisys saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 1,200,000 shares, an increase of 8.1% from the May 31st total of 1,110,000 shares. Based on an average daily volume of 318,000 shares, the short-interest ratio is presently 3.8 days. Approximately 3.8% of the company's shares are sold short. View Amedisys' Current Options Chain.

Some companies that are related to Amedisys include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), Davita (DVA), Chemed (CHE), LHC Group (LHCG), AMN Healthcare Services (AMN), MEDNAX (MD), R1 RCM (RCM), CorVel (CRVL), The Providence Service (PRSC), Tivity Health (TVTY), Cross Country Healthcare (CCRN) and Interpace Diagnostics Group (IDXG). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Amedisys investors own include Alibaba Group (BABA), NVIDIA (NVDA), Adobe (ADBE), Cisco Systems (CSCO), Netflix (NFLX), CVS Health (CVS), Intel (INTC), Micron Technology (MU), Pfizer (PFE) and Vertex Pharmaceuticals (VRTX).

Amedisys trades on the NASDAQ under the ticker symbol "AMED."

Shares of AMED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of AMED stock can currently be purchased for approximately $204.14.

Amedisys has a market capitalization of $6.61 billion and generates $1.96 billion in revenue each year. The health services provider earns $126.83 million in net income (profit) each year or $4.40 on an earnings per share basis. Amedisys employs 21,300 workers across the globe.

The official website for Amedisys is www.amedisys.com.

Amedisys' mailing address is 3854 AMERICAN WAY SUITE A, BATON ROUGE LA, 70816. The health services provider can be reached via phone at 225-292-2031 or via email at [email protected]